Skip to content
eHealthTutorial — Research Peptide Reviews
Investigational dual agonist

GLP-1/glucagon metabolic research

Survodutide

Survodutide is a dual GLP-1 and glucagon receptor agonist investigated in controlled metabolic studies. Phase 2 findings are not an FDA approval or a supplier-vial validation.

Open calculator Explore the research
Generic research visual — not a commercial product
Compound typeGLP-1/glucagon agonist peptide
Evidence baseRandomized phase 2 clinical trial
Regulatory contextInvestigational / Not FDA-approved
Page purposeResearch and calculation

Compound calculator

Survodutide reconstitution calculator

Enter the values printed on your vial and the liquid volume you added to calculate concentration, liquid volume, and the corresponding mark on a U-100 syringe scale.

Selected peptide or compoundSurvodutide
Enter the total amount printed on the vial.
mL
Enter the liquid volume added in milliliters.
You provide this amount; the calculator does not select or recommend it.
Scale reference only; confirm the markings on the physical syringe.

Your Survodutide calculation appears here

Enter the three required values to see the mathematical result.

This calculator performs arithmetic using values you enter. It does not select or recommend an amount, schedule, treatment, preparation method, or method of administration.

Research overview

What is Survodutide?

Survodutide engages both GLP-1 and glucagon receptors; it differs from mazdutide despite the same receptor targets. Trial formulations and chemical sequences are product-specific. A shared drug class does not establish interchangeability.

What has research examined?

A randomized, placebo-controlled 46-week phase 2 dose-finding trial across 12 countries evaluated weight outcomes and safety in adults with overweight or obesity without diabetes. Studied survodutide groups showed weight reductions, with adverse-event and tolerability considerations. These are clinical-program findings, not evidence that a research supplier’s powder matches the investigational product.

Important limitation

Phase 2 trials do not settle long-term efficacy, safety, regulatory approval, or vial identity. The optional calculator is arithmetic on user-provided numbers and recommends no amount or use.

Research references

Calculation boundary

The calculator performs concentration arithmetic only when a user enters a mass and liquid volume. It does not verify identity, formulation, purity, sterility, stability, compatibility, biological-unit equivalence, or whether reconstitution applies to a particular product. Do not convert IU or other biological units to mg without an authoritative, exact-product relationship.

For research purposes only. This page is educational and is not medical or veterinary advice or a recommendation to purchase, prepare, administer, or use any product.